Newborn screening for congenital adrenal hyperplasia (Q34246253)

31 July 2017

1 reference

title

Newborn screening for congenital adrenal hyperplasia. (English)

1 reference

31 July 2017

Therrell BL

1

1 reference

31 July 2017

1 March 2001

1 reference

Endocrinology and Metabolism Clinics of North America

31 July 2017

1 reference

31 July 2017

30

1 reference

31 July 2017

15-30

1 reference

31 July 2017

1

1 reference

Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Neonatal Screening Program for Congenital Adrenal Hyperplasia in a Homogeneous Caucasian Population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Elevated 17-hydroxyprogesterone and testosterone in a newborn with 3-beta-hydroxysteroid dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

An unusually high incidence of salt-losing congenital adrenal hyperplasia in the Alaskan Eskimo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

The magnitude and challenge of false-positive newborn screening test results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

15 beta-hydroxylated steroids may be diagnostically misleading in confirming congenital adrenal hyperplasia suspected by a newborn screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

A pilot newborn screening for congenital adrenal hyperplasia in Alaska

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Congenital adrenal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2808%2970017-3

7 January 2021

10.1016/S0889-8529(08)70017-3

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11344933